Gross Profit: Revenues from operations less the associated costs.
Aytu BioPharma, Inc. (AYTU) had Gross Profit of $10.41M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$16.11M |
|
$-0.01M |
|
$5.70M |
|
|
Gross Profit |
$10.41M |
$16.88M |
|
$-0.78M |
|
$0.77M |
|
$-0.00M |
|
$-0.00M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.78M |
|
$0.37M |
|
12.32M |
|
12.32M |
|
$0.21 |
|
$0.50 |
|
| Balance Sheet Financials | |
$61.76M |
|
$0.39M |
|
$43.25M |
|
$105.01M |
|
$54.66M |
|
$9.10M |
|
$15.07M |
|
$69.73M |
|
$35.27M |
|
$-6.13M |
|
$35.27M |
|
10.73M |
|
| Cash Flow Statement Financials | |
$3.28M |
|
$-0.03M |
|
$-7.90M |
|
$30.95M |
|
$26.31M |
|
$-4.64M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.13 |
|
-- |
|
-- |
|
0.21 |
|
0.48 |
|
64.63% |
|
-4.82% |
|
-4.82% |
|
-- |
|
-0.02% |
|
-0.09% |
|
$3.25M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.83 |
|
0.71 |
|
127.29 |
|
-0.04% |
|
0.24% |
|
-0.01% |
|
-0.03% |
|
$3.29 |
|
$0.26 |
|
$0.27 |
|